Cano Health, Inc.
CANO
CANO was delisted on the 2nd of February, 2024.
50 hedge funds and large institutions have $5.37M invested in Cano Health, Inc. in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 93 closing their positions.
3,519% more call options, than puts
Call options by funds: $16M | Put options by funds: $441K
13% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 15
63% less funds holding
Funds holding: 134 → 50 (-84)
78% less capital invested
Capital invested by funds: $24M → $5.37M (-$18.7M)
89% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 93
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$606K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$541K |
| 3 |
CCM
Connective Capital Management
Palo Alto,
California
|
+$505K |
| 4 |
D.E. Shaw & Co
New York
|
+$441K |
| 5 |
Two Sigma Investments
New York
|
+$328K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCAM
Owl Creek Asset Management
New York
|
-$2.44M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$1.01M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$989K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$717K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$431K |
CANO Hedge Fund Activity: Q4 2023 in Review
50 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. (CANO) for Q4 2023, worth a combined $5.37M — down 78% from $24M a quarter earlier.
Sellers outnumbered buyers: 93 funds closed out of CANO and 10 opened new positions — a net loss of 83 holders — while 15 trimmed existing stakes and 17 added.
The largest buyer was Qube Research & Technologies (QRT), opening a new position worth an estimated $606K. The largest seller was Owl Creek Asset Management, exiting entirely with an estimated $2.44M sold.
- 50 institutional investors held Cano Health, Inc. (CANO) as of Q4 2023, down from 134 in Q3 2023.
- Funds reported $5.37M of Cano Health, Inc. stock for Q4 2023, down 78% quarter-over-quarter.
- 10 funds opened new Cano Health, Inc. positions in Q4 2023 and 93 closed out, a net change of -83 holders.
- The largest Cano Health, Inc. buyer in Q4 2023 was Qube Research & Technologies (QRT), an estimated $606K added.
- The largest Cano Health, Inc. seller in Q4 2023 was Owl Creek Asset Management, an estimated $2.44M sold.
Based on aggregated 13F filings for Q4 2023.